- Open Access
Development and validation of behavioral intention measures of an E-vapor product: intention to try, use, dual use, and switch
Health and Quality of Life Outcomes volume 19, Article number: 123 (2021)
The harm caused by tobacco use is primarily attributable to cigarette smoking. Switching completely to non-combustible products may reduce disease risks in adult cigarette smokers who are unable or unwilling to quit. Before a new tobacco product can enter the market or can be marketed as a modified risk tobacco product, the manufacturer must determine the impact that the product will have on the likelihood of changes in tobacco use behavior among both tobacco users and nonusers. One way to estimate change in tobacco use behavior is to assess tobacco users’ and nonusers’ behavioral intentions toward the product and its marketing, including intentions to try, use, dual use, and switch to the product from cigarettes. The purpose of this study was to develop and validate behavioral intention metrics appropriate for use with current, former, and never adult tobacco users.
Preliminary items were subjected to cognitive testing with adult (1) smokers planning to quit cigarettes in the next 30 days, (2) smokers not planning to quit cigarettes in the next 30 days, (3) e-vapor users, (4) former tobacco users, and (5) never tobacco users. Items were iteratively revised based on feedback during cognitive testing, and surviving items were administered to a large sample of adults (N = 2943) representing the aforementioned sub-groups. Rating scale functioning, reliability, validity, bias, and ability to detect change were evaluated.
Examination of the response category thresholds generated by the Rasch model provided evidence that the rating scales were functioning appropriately. Results revealed good stability and excellent internal consistency and person reliability and provided evidence of unidimensionality and convergent validity. Estimates of reliability and validity were similar across sub-groups. A cross-validation sample generally confirmed findings from the validation sample. No items were discarded due to differential item function. Exploratory analyses provided support for ability to detect change.
Results from this rigorous, empirical evaluation using large validation and cross-validation samples provide strong support for the psychometric properties of the Intention to Try, Use, Dual Use, and Switch scales with current, former, and never adult tobacco users.
Most tobacco-related diseases are attributable to a cigarette smoker’s exposure to smoke. If adult smokers switch completely to non-combustible tobacco products, they may reduce their risk of smoking-related diseases. However, misperceptions hinder adult smoker adoption of potentially harm reducing non-combustible products. Adult smokers continue to have misperceptions regarding the role of nicotine and the relative risks of different tobacco products [1, 2]. For a manufacturer to sell a new, non-combustible tobacco product in the United States, it must be authorized by the Food and Drug Administration (FDA) through a manufacturer’s Premarket Tobacco Product Application (PMTA). To communicate that a non-combustible product may pose less risk than a combustible product, the FDA must determine that the product is a “modified risk tobacco product” using a manufacturer’s Modified Risk Tobacco Product Application (MRTPA). Both PMTAs and MRTPAs should include data on the effects of marketing and advertising on tobacco users’ and nonusers’ likelihood of trying and using the tobacco products. For example, the FDA’s Electronic Nicotine Delivery Systems (ENDS) PMTA Guidance recommends that applications incorporate evaluations of “use intentions among current ENDS users, nonusers, and other tobacco product users,” as well as the effects of the new tobacco product on users, “including effects on initiation, switching behavior, cessation, and dual use” . Additionally, the FDA’s MRTPA Draft Guidance asks manufacturers to provide behavioral data to assess the likelihood that tobacco product users or nonusers will start using the modified risk product (i.e., trial and use) and that tobacco users will use the modified risk product “in conjunction with other tobacco products” (i.e., dual use) . Lastly, from a public health perspective, there is an important distinction between trial and regular use of a product, as well as between dual use and switching, as these behaviors have different impacts on individual and population health.
Published literature, including a meta-analysis, has demonstrated an empirical causal relationship between intentions and behavior ; however, intentions should not be considered an exact proxy for behavior. The use of behavioral intentions to approximate and understand behavior in tobacco product research is consistent with FDA PMTA and MRTPA guidance [3, 4]. Moreover, collecting behavioral intentions data is necessary to provide evidence about new products and/or proposed modified risk communications that are not yet in the marketplace.
According to the FDA, validated items to capture behavioral intentions should be used in application submissions whenever possible . Indeed, utilizing valid behavioral intention metrics is important for research conducted in support of PMTAs and MRTPAs, including research that explores the impact of modified risk messaging on behavioral intentions. However, at the present time a validated instrument to measure tobacco-related behavioral intentions does not exist in the published literature. Furthermore, in addition to having evidence of reliability and validity, the ideal tobacco-related behavioral intentions metric should be appropriate for use with adult tobacco users and nonusers, sensitive enough to detect change, and able to be used with various types of tobacco products.
Currently, there is substantial variability in the assessment of tobacco-related behavioral intentions across industry, academia, and government research. For example, some experimental and survey research studies utilize single-item behavioral intention scales [7, 8], other studies utilize discrete choice or product selection to infer intentions or likelihood of use [9, 10], and other studies capture more specific aspects of intentions, such as smoking expectation or interest, in hypothetical MRTPs . Accordingly, our ability to compare results across studies and synthesize findings is limited when studies utilize different metrics (or correlates) of behavioral intentions. Having behavioral intention metrics with the idealistic qualities described above (e.g., reliability, validity, appropriate for tobacco users and nonusers, sensitive to detect change) may provide researchers in various contexts (academia, government, etc.) the opportunity to use a shared, psychometrically sound measurement tool.
The use of validated tobacco-related intentions metrics would directly address guidance from the FDA [3, 4] and help improve the quality of evidence gathered to support non-combustible tobacco product applications, including authorization of modified risk health communications to adult tobacco consumers. The authorized products and reduced harm communications ultimately play a critical role in moving smokers from cigarettes to noncombustible products.
The current research represents the development of measures to assess behavioral intentions among tobacco users and nonusers following the rigorous validation process consistent with FDA guidance  and widely accepted standards [13, 14]. For example, research followed a multi-step process that is consistent with the FDA Patient-Reported Outcome (PRO) Guidance to support labeling claims . Additionally, implementation of validated intention metrics, such as these behavioral intention measures, is consistent with recent FDA draft guidance . Specifically, this study presents the development and validation of the Intention to Try (ITT), Intention to Use (ITU), Intention to Dual Use (ITDU), and Intention to Switch (ITS) scales referencing e-vapor products. Assessing a range of intentions (e.g., ITT, ITS) appears to be consistent with the FDA’s framework to understand the likelihood of initiation, repeated use, and conversion to lower risk tobacco products .
The validation process employed in the current study included (1) development of the initial items, (2) item refinement based on cognitive interviews among tobacco users and nonusers and input from subject matter experts (SMEs), and (3) quantitative empirical evaluation.
A third-party vendor, Inflexxion, Inc. (Waltham, MA), collected and analyzed all data. A study protocol and supporting documents were submitted to Chesapeake IRB, reviewed under the Federal Policy for the Protection of Human Subjects (45 CFR Part 46), and the study was determined to be exempt from IRB oversight.
The initial pool of items was developed by a team of SMEs (N = 8; representing the fields of cognitive, social, and clinical psychology; neuropsychology; psychometrics; and market research), drawing from published literature [16,17,18]. Published items were modified and new items were developed to adequately capture behavioral intentions toward an e-vapor product. Initial items incorporated key concepts from the literature such as degree of commitment or readiness (e.g., “I am open” vs. “I will”), perceptions of one’s social network (e.g., likelihood of trying a product if a friend offered the product to you), different levels of progress (e.g., “gradually” switching vs. planning to use as a “complete replacement”), and different temporal dimensions, including time until implementation (i.e., 30 days, 6 months) and frequency of use (i.e., “try,” “more than once,” “regularly use,” “will be my regular brand”). This initial draft survey was then subject to testing through individual semi-structured cognitive debriefing interviews.
Cognitive interviewing is a qualitative research strategy used to improve the quality and accuracy of survey instruments. Through cognitive debriefing interviews, it is possible to identify and correct sources of response error in the survey and to verify that the survey (i.e., instructions, response options, items) is understood as intended, thereby enhancing and providing evidence of content validity [19, 20]. Retrospective probing techniques, which emphasize realism , were used in the current study.
Three experienced interviewers (two licensed clinical psychologists and a research assistant), trained on the semi-structured interviewing script and conducted in-person one-on-one interviews with participants over a three-day period at the Consumer Opinion Center (COC; https://www.consumeropinioncenter.com/) located in Virginia. Interviews were audio recorded to facilitate analysis, lasted approximately one hour, and participants were compensated $125 for their time.
After completing the informed consent, participants were asked to complete the survey independently while the interviewer observed, noting any potentially relevant behavioral observations (e.g., changing an answer). Next, using the semi-structured interviewing guide, the interviewer reviewed the survey item-by-item, including participants’ responses, with the participant. The interviewers utilized the general and specific probes from the interviewing guide, but also deviated as needed when signs of confusion, contradiction, or subtle misunderstandings were observed . General probes included: (1) How did you arrive at your answer? (2) Was there anything confusing about the question? (3) What do you think this question is asking? consistent with general probing guidelines as described by Byrom and Tiplady . Probes were intended to evaluate comprehension, retrieval, judgement, and response . Examples of specific probes included: What do you think they meant by “trying”? What do you think they mean by “expect to use” instead of “expect to try”? What do you think they mean by “smokes daily”? Why did you select [participant’s response] instead of [response option adjacent to participant’s response]?
The three interviewers each interviewed 2–3 participants per day over a 3-day period. At the end of each day, interviewers met to discuss participant feedback, to identify themes (i.e., instances where multiple participants provided the same feedback or probing revealed a similar misunderstanding or opportunity for improvement), and to assess saturation. Once interviews were complete, results (themes, representative participant quotes) were compiled into a report and used to guide survey revisions.
Participants were recruited by the contract research organization Celerion Inc. (Lincoln, NE) through the COC. Celerion recruited, contacted, and screened potentially eligible adults through their database and other recruitment methods (fliers, other advertisement materials) for inclusion in the study. To qualify for participation, participants had to: (1) be of legal age to purchase tobacco or older, whether or not they were a current user of tobacco, in the state and locality in which they resided, (2) provide voluntary consent, (3) acknowledge willingness and ability to comply with all study requirements, and (4) meet criteria for inclusion in one of the five study sub-groups. These study sub-groups included: adult (1) cigarette smokers planning to quit cigarettes in the next 30 days (ASPQ), (2) cigarette smokers not planning to quit in the next 30 days (ASNPQ), (3) e-vapor users (EV Users), (4) former tobacco users (Former Users), and (5) never tobacco users (Never Users).
Participants were recruited from a nationally representative online community of panelists who provided political and demographic information about themselves through PollingPoint, which was owned and operated by YouGov (London, UK; https://today.yougov.com/). Interested YouGov members completed a brief screener to determine eligibility. Inclusion criteria for this part of the study were the same inclusion criteria used during cognitive interviewing. Eligible participants who provided consent completed the electronic survey through the YouGov online survey platform. To ensure the findings obtained from the empirical evaluation were stable over sampling and generalizable across sub-groups, the survey was open until approximately 600 individuals per sub-group had participated.
Three days after completing the survey, a sub-sample of participants was re-contacted to complete the survey again to gather information about the items’ stability. Invitations were sent to members on a rolling basis after completing the initial survey until a minimum of 100 participants per sub-group had completed the retest. The sample size of n = 100 was derived from a power analysis to detect a significant difference between an intraclass correlation coefficient (ICC) of 0.80 (within the acceptable level) and 0.69 (below the acceptable level), assuming 80% power.
Participants completed an electronic survey that included questions about demographics, tobacco use history and current tobacco use, and the behavioral intention items. Before exposure to the behavioral intention items, participants were provided with a brief description of the e-vapor products, as well as the instructions: Please rate the extent to which you agree or disagree with the following items. We realize you may not know the answer to each question, but please provide your best answer. Please refer to the description [of the product] above to help you answer the following items.
Participants responded to the behavioral intention items shown in Table 3. Multi-item scales (ITT, ITU, ITS) were scored by calculating a mean of the items within each scale.
After answering the behavioral intention items, participants responded to a Behavioral Selection task, adapted from previous research : If we have the opportunity to send you one of the products listed below for free, which of the products would you choose? One of the [specific brand] e-vapor products / another e-vapor product not shown / gas card of similar value as an e-vapor product / I would not wish to receive any of these. For purposes of evaluating convergent validity and ability to detect change, the Behavioral Selection task was collapsed into a binary variable to reflect those who selected One of the [specific brand] e-vapor products vs. those who made an alternative response selection.
The empirical evaluation was an iterative process, which included both modern test theory and classical test theory (CTT) approaches. First, a Rasch partial credit model  was employed in WINSTEPS analysis software to evaluate rating scale functioning. An important assumption underlying the use of a Likert-type rating scale is monotonicity, i.e., it requires greater intention to endorse a higher (more severe) response option (e.g., Agree vs. Strongly Agree). This assumption was empirically evaluated by examining the order of the response option Andrich thresholds estimated by the Rasch model, where response option Andrich thresholds are defined as the trait level at which a respondent has an equal probability of endorsing adjacent categories .
Second, unidimensionality, adequate item fit, and item discrimination were evaluated. Unidimensionality was evaluated in three ways:
In WINSTEPS, unidimensionality was evaluated by conducting a principal component analysis (PCA) on the probability scale residuals estimated from the Rasch model . Additionally, factor sensitivity ratios  were calculated by dividing the residual variance eigenvalue units by the Rasch measure variance eigenvalue units [26, 27];
Monte Carlo simulations (“parallel analyses”) of 10,000 randomly generated parallel datasets were conducted to determine the number of significant factors derived from the PCA . The eigenvalues derived from the PCA were compared against the 95th percentile of the distribution of the randomly generated eigenvalues to determine the number of significant factors;
a one-factor, first-order confirmatory factor analysis was employed to confirm the unidimensional structure of the scales using the cross-validation sample data in AMOS.
Item fit and item discrimination were evaluated by examining inlier and outlier item mean squares and discrimination statistics generated from WINSTEPS.
Third, to evaluate reliability, person reliability coefficients were generated from WINSTEPS. Additionally, internal consistency reliability was estimated using Cronbach’s α and test–retest reliability was captured by an ICC using absolute agreement.
Fourth, convergent validity was established by examining the relationship between behavioral intentions and selection of one of the [specific brand] e-vapor products on the Behavioral Selection task by employing Pearson correlations. Significant positive correlations were anticipated between intentions and selection of one of the [specific brand] e-vapor products on the Behavioral Selection task.
Fifth, bias with respect to gender, race (White/non-White), age (legal age to 24 years vs. > 24 years), and sub-group membership was evaluated via differential item function (DIF) . An item was considered to have little or no difference between groups if the DIF Mantel–Haenszel contrast estimate was < 1 in absolute value and the p-value was non-significant [30, 31]. Of note, bias was evaluated for young adults (legal age to 24 years) compared to older adults because young adults are a population of interest to the FDA . Bias was evaluated using the full sample to ensure that the sample sizes were large enough to achieve stable estimates.
Finally, we explored the scales’ ability to detect change in behavioral intentions over time. That is, while little to no true change in behavioral intentions was expected to occur during the three-day interval of time between administrations, any change would be expected to correspond with change in participants’ selection of one of the [specific brand] e-vapor products on the Behavioral Selection task. Ability to detect change was estimated by correlating residualized change scores  between the intentions scales and the Behavioral Selection task captured during the first and second test administrations.
Internal structure, internal consistency reliability, test–retest reliability, and convergent validity were evaluated across the five study sub-groups. Analyses were confirmed using a cross-validation sample.
In total, 23 cognitive interviews were completed. The mean age of participants was 43.7 years (standard deviation [SD] = 12.3), and the majority of participants identified as male (73.9%). Approximately half of the participants reported full-time employment, and most participants had obtained a high school diploma/GED (39.1%) or completed some college (43.5%).
Items were iteratively removed or revised as appropriate based on themes identified from cognitive interviews in conjunction with SME input. For example, for the ITU measures, the original 5-point rating scale included a middle category "Neither Agree or Disagree." However, cognitive testing revealed that participants were interpreting and utilizing this category in meaningfully different ways (i.e., "I do not have an opinion," "I have mixed opinions"), threatening the validity of the response scale and increasing measurement error. Therefore, "Neither Agree or Disagree" was replaced with "Somewhat agree" and "Somewhat disagree," resulting in a 6-point scale. Additionally, prior to the empirical evaluation, SMEs made final selections regarding which items from the pool would be retained for purposes of capturing ITT, ITU, ITDU, and ITS in an effort to reduce scale length and respondent burden. Surviving items were subject to empirical evaluation.
Of the 40,604 participants who completed the screening, 32,488 did not meet inclusion criteria, 5173 provided incomplete or unusable data (i.e., completed the full survey in the top 2% of fastest times [under 5 min]), and 2943 completed the survey (full sample). Demographic characteristics for the full sample (N = 2943) and five sub-groups are presented as an additional file (see Additional file 1). Of the 2943 participants, 562 completed the second administration of the survey (ASPQ n = 101, ASNPQ n = 107, EV Users n = 104, Former Users n = 118, Never Users n = 132). The full sample was randomly split into validation (n = 1495) and cross-validation (n = 1448) samples. Participant demographic characteristics were similar across the five sub-groups, as well as between the validation and cross-validation samples (see Tables 1 and 2).
Of note, as the ITDU scale consisted of a single item, only test–retest reliability and convergent validity were evaluated. The final behavioral intention items and their rating scales are presented in Table 3.
Rating scale functioning
Evaluation of rating scale performance revealed ordered thresholds, suggesting that a higher level of intention is required to endorse a greater level of agreement or likelihood. To illustrate, response category thresholds among all participants in the validation sample are presented in Table 4.
The PCA on the probability scale residuals revealed that the Rasch model explained 81.2%, 84.0%, and 85.9% of the raw variance in the ITT, ITU, and ITS scales. Additionally, factor sensitivity ratios  for the ITT, ITU, and ITS scales were 13.3%, 8.4%, and 8.6%, respectively, suggesting the absence of multiple dimensions [26, 27].
Using the validation sample data, parallel analyses were conducted with each of the five sub-groups for each intention scale. The eigenvalues associated with the first factor was the only significant eigenvalue, providing support for unidimensionality of the scales with all five sub-groups. Finally, factor loading estimates and goodness-of-fit indices from the confirmatory factor analyses using the cross-validation sample provided additional support for unidimensionality (Table 5).
All items evidenced adequate fit statistics (both infit and outfit values were not > 1.50) , suggesting that the items were functioning as expected for the Rasch model. Moreover, item discrimination values, estimated outside of the Rasch model, produced good fit to the model (approximately 0.5 to 1.7) .
Person reliability coefficients (derived from the Rasch model) for the ITT, ITU, and ITS scales were 0.87, 0.92, and 0.90, respectively, providing evidence that the scales are able to accurately quantify persons with different levels of intention. Internal consistency reliability estimates were consistently high across subgroups (Cronbach’s α = 0.876—0.985) (Table 6). Test–retest reliability coefficients were largely moderate to good  (absolute ICC = 0.650—0.858), except for the reliability coefficient for ITDU among EV Users (absolute ICC = 0.395). The substantial discrepancy between the validation and cross-validation sample ITDU stability coefficients for EV Users suggests that the sample sizes were too small to yield stable estimates (n = 24). Therefore test–retest reliability for ITDU among EV Users was recalculated using the full sample (n = 48; absolute ICC = 0.544, p < 0.001).
Aside from the aforementioned exception, results using the cross-validation sample were generally consistent with findings using the validation sample.
As evidence of convergent validity, there was a significant positive association between intentions and selection of one of the [specific brand] e-vapor products on the Behavioral Selection task (Table 7). Results from the cross-validation sample confirmed this finding.
The ITT and ITS items did not exhibit substantial DIF for gender, race, age, or sub-group membership. While the ITU items did not exhibit substantial DIF for gender, race, or age, of the 40 between sub-group DIF comparisons, five emerged as significant. That is, “Use1” exhibited some evidence of DIF between the Never User group and the ASPQ, ASNPQ, and EV User groups, and “Use4” exhibited some evidence of DIF between the Never User group and the ASPQ and ASNPQ groups. However, these DIF contrasts were in the opposite direction (e.g., Use1 was more difficult for Never Users to endorse, and Use4 was easier for Never Users to endorse), suggesting that DIF is broadly cancelled out when an ITU composite is calculated . Consequently, no items were discarded due to DIF.
Ability to detect change
Change in intention scores over a three-day test–retest period corresponded with change in selection of one of the [specific brand] e-vapor products on the Behavioral Selection task, evidenced by positive associations between residualized change scores (see Table 8). That is, participants who did not select one of the [specific brand] e-vapor products at the first Behavioral Selection task administration and then later selected one of the [specific brand] e-vapor products at the second task administration also reported an increase in behavioral intentions.
Administration and scoring
The ITT, ITU, ITDU, and ITS scales were empirically validated in electronic form. Therefore, the extent to which the psychometric properties obtained through the current empirical validation generalize to a paper-and-pencil form is unknown. As such, electronic administration of the behavioral intention scales is recommended. The scales are scored by calculating a mean of the items within that scale. If response to an item is missing, a composite for that construct should not be calculated.
This is the first scientific publication to date describing the successful development and validation of instruments to measure tobacco-related behavioral intentions, including ITT (n = 3 items), ITU (n = 4 items), ITDU (n = 1 item), and ITS (n = 3 items) scales. Results from these behavioral measures can provide evidence to the FDA supporting PMTAs and MRTPAs on how adult smokers might use a new, non-combustible product or a non-combustible product with a reduced harm claim. Rasch modeling was employed to evaluate rating scale functioning and results suggested that the 6-point rating scales were functioning as expected. Multi-item scales were found to be unidimensional, and the scales evidenced excellent internal consistency and person reliability and good stability. Results provided support for convergent validity and exploratory analyses suggested that the scales may be able to detect true change over time. Lastly, none of the items exhibited significant DIF based on gender, race, or age. Although there was some evidence of DIF between sub-groups for two of the ITU items, these differences were considered inconsequential when computing composite scores.
It is noteworthy that estimates of internal structure, internal consistency reliability, test–retest reliability, and convergent validity were largely consistent across the five sub-groups. Taken together, the results suggest that the behavioral intention scales can be used across these different populations and direct comparisons between populations can be made without modifying scoring. The findings were robust as evidenced by similar results across validation and cross-validation samples. Results from this comprehensive evaluation also provide evidence that the Intention scales are appropriate for use among adult tobacco users, former users, and never users. This study helps support research conducted for tobacco regulatory applications by providing a valid measure of behavioral intentions, which is one important factor to consider in the overall assessment of tobacco use behavior.
The success of these scales may be partially due to the reliance on cognitive testing for item development, where qualitative feedback was obtained from a diverse group of participants with different types of experience with tobacco products. Qualitative testing likely improved the clarity of the scales (including the instructions, item content, and response options) and increased the content validity of the items. Additionally, the large sample size utilized in the empirical evaluation allowed for assessment of item functioning across sub-groups of participants. Separate evaluation of scale functioning across groups of tobacco users and nonusers is important to ensure adequate and similar psychometric functioning between groups.
In the current study, the behavioral intention items were validated in reference to a specific e-vapor brand. Recent research has also demonstrated that these intention scales are valid when modified to reference other tobacco and/or nicotine products, namely, an oral product containing tobacco-derived nicotine and a moist snuff tobacco product . Specifically, the results of this research suggest that (1) the scales are reliable and valid when modified to reference other tobacco products, and (2) the intention scales function similarly (i.e., do not exhibit substantial DIF) across tobacco products.
For smokers to realize reduced risk of certain smoking-related diseases from non-combustible products, they must completely switch from cigarettes to the non-combustible product. The results presented here offer successful validation of behavioral intention measures that researchers and the public health community can use to better evaluate the impact of introducing a potentially reduced risk product or product with a reduced harm claim into the marketplace.
Limitations and future research
The stability of the ITDU item over the three-day test–retest period was lower than anticipated for the EV User group. This finding may reflect greater fluctuation in e-vapor users’ true intention to dual use different e-vapor products. However, it should also be noted that absolute agreement in participants’ responses to the dual use item (ICC with absolute agreement) reflects a rather conservative estimate of scale reliability .
Cognitive testing relied on a convenience sample of participants from the Richmond, Virginia area. Inclusion of participants from other geographic locations may have improved wording of the items for use with individuals from other areas of the country. However, it should be noted that the sample from the Richmond location consisted of diverse groups of individuals across key demographic variables, including age, gender, and race as well as tobacco use history. The online sampling for the quantitative evaluation was devised to obtain a demographic distribution reflective of the US population from a nationally representative panel through PollingPoint, formerly of YouGov.
This research was conducted using adult (legal age to use tobacco and older) tobacco users and nonusers. Therefore, the extent to which these items are appropriate to capture behavioral intentions in youth cannot be inferred from this study.
An important next avenue of research will be to evaluate the predictive validity of the behavioral intention scales through longitudinal research that captures actual behavior. Evaluating the relationship between responses to these behavioral intention items and actual behavior would facilitate the development of cut points. Future research might also evaluate the scales’ ability to detect change over a longer period of time.
Despite the stated limitations, results from this evaluation provide support for the psychometric properties of the ITT, ITU, ITDU, and ITS scales specifying an e-vapor product with current, former, and never adult tobacco users.
For new, non-combustible products or reduced harm claims to be authorized by the FDA, they must be supported by research demonstrating adult tobacco users’ and nonusers’ intentions to try and use, and adult tobacco users’ intentions to dual use or switch to the products. This study presents the first development and validation of behavioral intention scales appropriate for research studies supporting PMTAs and MRTPAs. Results from a comprehensive empirical evaluation provide evidence of reliability and validity of the ITT, ITU, ITDU, and ITS scales with current, former, and never adult tobacco users. Given the scales’ strong psychometric properties, these behavioral intention metrics may be used to capture changes in intention following exposure to modified risk messaging, marketing, and/or advertising.
Availability of data and materials
Reasonable requests for datasets and/or analyses presented in this manuscript will be considered as appropriate, recognizing that the data is currently subject to review as part of a proprietary product application pending with FDA.
Adult smoker not planning to quit
Adult smoker planning to quit
Comparative fix index
Consumer Opinion Center
Classical test theory
Differential item function
Electronic Nicotine Delivery Systems
Food and Drug Administration
Goodness of fit index
Intraclass correlation coefficient
Institutional review board
Intentions to Try
Intentions to Use
Intentions to Dual Use
Intentions to Switch
Modified Risk Tobacco Product Application
Principal components analysis
Premarket Tobacco Product Application
Root mean square error of approximation
Subject matter expert
O’Brien EK, Nguyen AB, Persoskie A, Hoffman ACUS. adults’ addiction and harm beliefs about nicotine and low nicotine cigarettes. Prev Med. 2017;96:94–100.
Steinberg MB, Bover Manderski MT, Wackowski OA, Singh B, Strasser AA, Delnevo CD. Nicotine Risk Misperception Among US Physicians. J Gen Intern Med. 2020.
FDA. Premarket tobacco product applications for electronic nicotine delivery systems: Guidance for industry. Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products; 2019.
FDA. Modified Risk Tobacco Product Applications: Draft Guidance. Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products; 2012.
Webb TL, Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull. 2006;132(2):249–68.
FDA. Guidance for industry: Tobacco products: Principles for designing and conducting tobacco product perception and intention studies. Draft guidance. 2020.
Mays D, Smith C, Johnson AC, Tercyak KP, Niaura RS. An experimental study of the effects of electronic cigarette warnings on young adult nonsmokers’ perceptions and behavioral intentions. Tob Induc Dis. 2016;14(17):1–10.
PATH. PATH Study Wave 1 Adult Restricted Use file: Annotated Instrument. 2015.
Kotnowski K, Fong GT, Gallopel-Morvan K, Islam T, Hammond D. The impact of cigraette packaging design among young females in Canada: findings from a discrete choice experiment. Nicotine Tobacco Res. 2016;18(5):1348–56.
Fix BV, Adkinson SE, O’Connor RJ, Bansal-Travers M, Cummings KM, Rees VW, et al. Evaluation of modified risk claim advertising formats for Camel Snus. Health Educ J. 2017;76(8):971–85.
Blanton H, Snyder LB, Strauts E, Larson JG. Effect of graphic cigarette warnings on smoking intentions in young adults. PLoS ONE. 2014;9(5):e96315.
FDA. Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims. 2009.
AERA, APA, NCME. Standards for educational and psychological testing. Washington, DC: American Educational Research Association; 2014.
Chan EKH. Standards and guidelines for validation practices: development and evaluation of measurement instruments. In: Zumbo BD, Chan EKH, editors. Validity and validation in social, behavioral, and health sciences. Social indicators research series. Cham: Springer International Publishing; 2014.
FDA. PMTA for ENDS Informational Session 2016.
Berg CJ, Barr DB, Stratton E, Escoffery C, Kegler M. Attitudes toward e-cigarettes, reasons for initiating e-cigarette use, and changes in smoking behavior after initiation: a pilot longitudinal study of regular cigarette smokers. Open J Prev Med. 2014;4(10):789–800.
Popova L, Ling PM. Nonsmokers’ responses to new warning labels on smokeless tobacco and electronic cigarettes: an experimental study. BMC Public Health. 2014;14(1):997–1007.
Rise J, Kovac V, Kraft P, Moan IS. Predicting the intention to quit smoking and quitting behaviour: extending the theory of planned behaviour. Br J Health Psychol. 2008;13(2):291–310.
Byrom B, Tiplady B. EPro: Electronic solutions for patient-reported data. Surrey: Gower Publishing Limited; 2010.
Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity—Establishing and reporting the evidence in newly devleoped patient-repoted outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing respondent understanding. Value Health. 2011;14:978–88.
Smith DM, Bansal-Travers M, O’Connor RJ, Goniewicz ML, Hyland A. Associations between perceptions of e-cigarette advertising and interest in product trial amongst US adult smokers and non-smokers: results from an internet-based pilot survey. Tob Induc Dis. 2015;13(1):14.
Masters GN. A Rasch model for partial credit scoring. Psychometrika. 1982;47:149–74.
Andrich D. Application of a psychometric rating model to ordered categories which are scored with successive integers. Appl Psychol Meas. 1978;2(4):581–94.
Bond TG, Fox CM. Applying the Rasch Model: fundamental measurement in the human sciences. 2nd ed. New York: Routledge; 2007.
Wright BD, Stone MH. Making measures. Chicago: The Phaneron Press; 2004.
Raiche G. Critical eigenvalue sizes in standardized residual principal components analysis. Rasch Meas Trans. 2005;19(1):1012.
Linacre JM. Winsteps® Rasch measurement computer program User’s Guide. Beaverton: Winsteps.com; 2017.
O’Connor BP. SPSS and SAS programs for determining the number of components using parallel analysis and Velicer’s MAP test. Behav Res Methods Instrum Comput. 2000;32(3):396–402.
Embretson SE, Reise SP. Item response theory for psychologists. Mahwah: Erlbaum Publishers; 2000.
Clauser BE, Mazor KM. Using statistical procedures to identify differentially functioning test items. Educ Meas Issues Pract. 1998;17(1):31–44.
Zieky M. A DIF primer. Center for Education in Measurement. 2003.
FDA. Modified Risk Tobacco Product Applications: Draft Guidance. 2012.
Waltz CF, Strickland OL, Lenz ER. Measurement in nursing and health research. 4th ed. New York: Springer; 2010.
Linacre JM. Winsteps Rasch measurement computer program. Beaverton: Winsteps; 2012.
IBM. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.; 2011.
Arbuckle JL. Amos (Version 20.0) [Computer Program]. Chicago: IBM SPSS; 2011.
Linacre JM. Item discrimination and infit mean-squares. Rasch Meas Trans. 2000;14(2):743.
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155–63.
Kleinman M, Teresi JA. Differential item functioning magnitude and impact measures from item response theory models. Psychol Test Assess Model. 2016;58(1):79–98.
McCaffrey S, Black R, Plunkett S. Psychometric evaluation of behavioral intention item functioning across tobacco product categories. Poster presented at: Society for Research on Nicotine and Tobacco 26th Annual Meeting Mar 11–14; New Orleans, LA, 2020.
This work was funded by Altria Client Services LLC.
Ethics approval and consent to participate
This study was reviewed by the Chesapeake IRB (reference number Pro00019036) and was determined to be exempt from IRB oversight. For both phases of the research (cognitive testing, the electronic survey), participants received complete information about the study before agreeing with an informed consent statement.
Consent for publication
At the time this manuscript was submitted, J.P.Z., S.P., E.B., and J.L. were employees of Altria Client Services LCC. S.A.M. and R.A.B. were employed at JUUL Labs Inc. and were former employees of Altria Client Services LLC.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
. Participant Demographic Characteristics Across the Full Sample and 5 Sub-groups. Description of data: Summary of participant demographic characteristics for the full study sample, as well as for the five study sub-groups.
About this article
Cite this article
McCaffrey, S.A., Zdinak, J.P., Plunkett, S. et al. Development and validation of behavioral intention measures of an E-vapor product: intention to try, use, dual use, and switch. Health Qual Life Outcomes 19, 123 (2021). https://doi.org/10.1186/s12955-021-01764-2
- Behavioral intention
- Psychometric validation
- Rasch model
- Intention to switch
- Public health